Summary by Futu AI
JUN SHENG TAI PHARMACEUTICAL-B (02511.HK) FILED ITS LATEST SECURITIES CHANGE MONTH REPORT WITH HONG KONG TRADING AND SETTLEMENT LIMITED ON APRIL 2, 2024, REPORTING CHANGES IN THE COMPANY'S SHARE CAPITAL AS OF MARCH 31, 2024. The report shows that the company's regulary/registered share capital and issued shares remained unchanged during the reporting period. The regulary/registered share capital was $1,000,000,000 shares with a face value of $0.0001, and the total remained at $100,000. In addition, the report confirms that the securities issued by the company this month have been formally authorized by the Board of Directors and have met all pre-listing regulatory requirements. Dr. Liu Liping, Executive Director and Chief Executive Officer, is the submitter of this report.